Literature DB >> 19585354

Primary intraocular lymphoma: diagnosis and differential diagnosis.

H Nida Sen1, Bahram Bodaghi, Phuc Le Hoang, Robert Nussenblatt.   

Abstract

Diagnosis of PIOL can be challenging. It requires a high degree of clinical suspicion and differential diagnosis includes infectious and non-infectious etiologies particularly the common masquaraders sarcoidosis, tuberculosis, viral retinitis and syphilis. The definitive diagnosis depends on demonstration of malignant lymphoma cells in ocular specimens or CSF. Ocular specimen could include vitreous, aqueous or chorioretinal biopsy. Ocular pathologist should be consulted prior to the diagnostic procedure to help handle and process the specimen appropriately. In addition to cytology, flow cytometry, immunohistochemistry, molecular analysis and cytokines may be used as adjuncts in facilitating the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585354      PMCID: PMC2924171          DOI: 10.1080/09273940903108544

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  55 in total

1.  Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion.

Authors:  G A Levy-Clarke; G A Byrnes; R R Buggage; D F Shen; A C Filie; R C Caruso; R B Nussenblatt; C C Chan
Journal:  Retina       Date:  2001       Impact factor: 4.256

2.  Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis.

Authors:  Michel Drancourt; Didier Raoult; Hubert Lépidi; Florence Fénollar; Marie-Laure Birg; Bahram Bodaghi; Phuc Le Hoang; Jean-Daniel Lelièvre
Journal:  Ann Intern Med       Date:  2003-12-16       Impact factor: 25.391

3.  Vitreous cytokine levels.

Authors:  Lesley A Wolf; George F Reed; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

4.  Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma.

Authors:  D F Shen; C P Herbort; N Tuaillon; R R Buggage; C E Egwuagu; C C Chan
Journal:  Mod Pathol       Date:  2001-10       Impact factor: 7.842

5.  Real-time quantitative polymerase chain reaction diagnosis of infectious posterior uveitis.

Authors:  Lydia L Dworkin; Therese M Gibler; Russell N Van Gelder
Journal:  Arch Ophthalmol       Date:  2002-11

Review 6.  Intraocular lymphoma.

Authors:  Chi-Chao Chan; Ronald R Buggage; Robert B Nussenblatt
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

7.  Characterization of vitreous B-cell infiltrates in patients with primary ocular lymphoma, using CDR3 size polymorphism analysis of antibody transcripts.

Authors:  Guy Gorochov; Christophe Parizot; Bahram Bodaghi; Darren Raphael; Nathalie Cassoux; Hélène Merle-Beral; Patrice Debré; Phuc LeHoang
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-12       Impact factor: 4.799

8.  Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.

Authors:  Sarah E Coupland; Nikolaos E Bechrakis; Gerasimos Anastassiou; Andreas M H Foerster; Arnd Heiligenhaus; Uwe Pleyer; Michael Hummel; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-30       Impact factor: 3.117

Review 9.  Ocular manifestations of human T-cell lymphotropic virus type 1 infection.

Authors:  Ronald R Buggage
Journal:  Curr Opin Ophthalmol       Date:  2003-12       Impact factor: 3.761

10.  Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.

Authors:  P M Hoffman; P McKelvie; A J Hall; R J Stawell; J D Santamaria
Journal:  Eye (Lond)       Date:  2003-05       Impact factor: 3.775

View more
  31 in total

1.  Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.

Authors:  Keisuke Kimura; Yoshihiko Usui; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2012-06-05       Impact factor: 2.447

2.  Diagnosis of systemic metastatic retinal lymphoma.

Authors:  Xiaoguang Cao; Defen Shen; David G Callanan; Manabu Mochizuki; Chi-Chao Chan
Journal:  Acta Ophthalmol       Date:  2011-03       Impact factor: 3.761

3.  One-port vs. three-port diagnostic vitrectomy for posterior segment diseases of unknown origin.

Authors:  Marco Coassin; Lorenzo Braconi; Giancarlo Sborgia; Giuseppe Mangano; Valentina Mastrofilippo; Antonio Di Zazzo; Luigi Fontana; Luca Cimino
Journal:  Int Ophthalmol       Date:  2020-07-09       Impact factor: 2.031

Review 4.  Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.

Authors:  Chi-Chao Chan; H Nida Sen
Journal:  Discov Med       Date:  2013-02       Impact factor: 2.970

5.  Primary intraocular central nervous system lymphoma masquerading as diffuse retinal vasculitis.

Authors:  Deeksha Katoch; Reema Bansal; Raje Nijhawan; Amod Gupta
Journal:  BMJ Case Rep       Date:  2013-04-30

6.  25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature.

Authors:  Mozhgan Rezaei Kanavi; Masoud Soheilian; Sayed Bagher Hosseini; Amir A Azari
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

7.  Anaplastic large cell lymphoma involving anterior segment of the eye.

Authors:  Choul Yong Park; Sang Won Hwang; Do Yeun Kim; Hee Jin Huh; Jong-Hyun Oh
Journal:  Korean J Ophthalmol       Date:  2014-01-21

Review 8.  Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how?

Authors:  Cindy S Hwang; Steven Yeh; Chris S Bergstrom
Journal:  Int Ophthalmol Clin       Date:  2014

9.  The future of primary intraocular lymphoma (retinal lymphoma).

Authors:  Chi-Chao Chan; Sylvain Fisson; Bahram Bodaghi
Journal:  Ocul Immunol Inflamm       Date:  2009 Nov-Dec       Impact factor: 3.070

10.  Neoplastic masquerade syndromes in patients with uveitis.

Authors:  Landon K Grange; Amr Kouchouk; Monica D Dalal; Susan Vitale; Robert B Nussenblatt; Chi-Chao Chan; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-11-06       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.